Exact Mass: 435.2305

Exact Mass Matches: 435.2305

Found 74 metabolites which its exact mass value is equals to given mass value 435.2305, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Valsartan

(2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid

C24H29N5O3 (435.227)

Valsartan is an angiotensin-receptor blocker (ARB) that may be used to treat a variety of cardiac conditions including hypertension, diabetic nephropathy and heart failure. Valsartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Valsartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].

N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine

3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid

C24H29N5O3 (435.227)

Protostemodiol

Protostemodiol

C23H33NO7 (435.2257)

Tongolenine D

Tongolenine D

C23H33NO7 (435.2257)

stemona-lactam M

stemona-lactam M

C23H33NO7 (435.2257)

Arg Phe Asn

Arg Phe Asn

C19H29N7O5 (435.223)

Arg Asn Phe

Arg Asn Phe

C19H29N7O5 (435.223)

Asn Arg Phe

Asn Arg Phe

C19H29N7O5 (435.223)

FNR

FNR

C19H29N7O5 (435.223)

Phe Arg Asn

Phe Arg Asn

C19H29N7O5 (435.223)

asparagylphenylalanylarginine

asparagylphenylalanylarginine

C19H29N7O5 (435.223)

Valsartan

Valsartan (Diovan)

C24H29N5O3 (435.227)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1075 CONFIDENCE standard compound; INTERNAL_ID 1112 CONFIDENCE standard compound; INTERNAL_ID 8608 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2583 INTERNAL_ID 1112; CONFIDENCE standard compound Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].

Cilazapril Monohydrate

Cilazapril monohydrate (Inhibace)

C22H33N3O6 (435.2369)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Phe Gly Gly Arg

(2S)-2-(2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}acetamido)-5-carbamimidamidopentanoic acid

C19H29N7O5 (435.223)

Phe Gly Arg Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanamido]acetic acid

C19H29N7O5 (435.223)

Phe Arg Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetamido}acetic acid

C19H29N7O5 (435.223)

Gly Phe Gly Arg

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H29N7O5 (435.223)

Gly Phe Arg Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C19H29N7O5 (435.223)

Gly Gly Phe Arg

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C19H29N7O5 (435.223)

Gly Gly Arg Phe

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C19H29N7O5 (435.223)

Gly Arg Phe Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetic acid

C19H29N7O5 (435.223)

Gly Arg Gly Phe

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanoic acid

C19H29N7O5 (435.223)

Lys Ser Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Lys Thr Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Lys Thr Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H33N5O8 (435.2329)

Asn Phe Arg

Asn Phe Arg

C19H29N7O5 (435.223)

Arg Phe Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]acetamido}acetic acid

C19H29N7O5 (435.223)

Arg Gly Phe Gly

2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-phenylpropanamido]acetic acid

C19H29N7O5 (435.223)

Arg Gly Gly Phe

(2S)-2-(2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}acetamido)-3-phenylpropanoic acid

C19H29N7O5 (435.223)

Ser Lys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Ser Thr Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]hexanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Ser Thr Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]hexanoic acid

C17H33N5O8 (435.2329)

Phe Asn Arg

Phe Asn Arg

C19H29N7O5 (435.223)

Thr Lys Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Thr Lys Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H33N5O8 (435.2329)

Thr Ser Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxybutanoic acid

C17H33N5O8 (435.2329)

Thr Ser Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]hexanoic acid

C17H33N5O8 (435.2329)

Thr Thr Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]hexanamido]-3-hydroxypropanoic acid

C17H33N5O8 (435.2329)

Thr Thr Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]hexanoic acid

C17H33N5O8 (435.2329)

Cortisol 3-(O-carboxymethyl)oxime

Cortisol 3-(O-carboxymethyl)oxime

C23H33NO7 (435.2257)

Clofilium phosphate

Clofilium phosphate

C21H39ClNO4P (435.2305)

1-(S)- CIS 9-AMINOOCTAHYDRO-10-OXO-6H-PYRIDAZINO[1,2-A][1,2]DIAZEPINE-1-CARBOXYLIC ACID, T-BUTYL ESTER

1-(S)- CIS 9-AMINOOCTAHYDRO-10-OXO-6H-PYRIDAZINO[1,2-A][1,2]DIAZEPINE-1-CARBOXYLIC ACID, T-BUTYL ESTER

C22H33N3O6 (435.2369)

D-Valsartan

D-Valsartan

C24H29N5O3 (435.227)

2-{4-[4-({4-[2-Methyl-1-(1-Methylethyl)-1h-Imidazol-5-Yl]pyrimidin-2-Yl}amino)phenyl]piperazin-1-Yl}-2-Oxoethanol

2-{4-[4-({4-[2-Methyl-1-(1-Methylethyl)-1h-Imidazol-5-Yl]pyrimidin-2-Yl}amino)phenyl]piperazin-1-Yl}-2-Oxoethanol

C23H29N7O2 (435.2383)

3beta,14beta-dihydroxy-5beta-pregnane-20-one-21-O-malonylhemiester

3beta,14beta-dihydroxy-5beta-pregnane-20-one-21-O-malonylhemiester

C24H35O7- (435.2383)

N-(2-furanylmethyl)-N-[4-methyl-2-(4-methyl-1-piperazinyl)-6-quinolinyl]butanediamide

N-(2-furanylmethyl)-N-[4-methyl-2-(4-methyl-1-piperazinyl)-6-quinolinyl]butanediamide

C24H29N5O3 (435.227)

Arg-Asn-Phe

Arg-Asn-Phe

C19H29N7O5 (435.223)

N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

[(1S)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C26H30FN3O2 (435.2322)

[(1R)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1R)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C26H30FN3O2 (435.2322)

N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C22H33N3O6 (435.2369)

Arg-Phe-Asn

Arg-Phe-Asn

C19H29N7O5 (435.223)

Asn-Arg-Phe

Asn-Arg-Phe

C19H29N7O5 (435.223)

Asn-Phe-Arg

Asn-Phe-Arg

C19H29N7O5 (435.223)

Phe-Arg-Asn

Phe-Arg-Asn

C19H29N7O5 (435.223)

Phe-Asn-Arg

Phe-Asn-Arg

C19H29N7O5 (435.223)

Cilazapril monohydrate (Inhibace)

Cilazapril monohydrate (Inhibace)

C22H33N3O6 (435.2369)

N-Pentanoyl-N-{[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine

N-Pentanoyl-N-{[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine

C24H29N5O3 (435.227)

ST 21:3;O5;Gly

ST 21:3;O5;Gly

C23H33NO7 (435.2257)

(3s,5s)-5-[(3s,8s,9r,9as)-8-hydroxy-9-[(2s)-1-(5-hydroxy-3-methoxy-4-methylfuran-2-yl)-1-oxopropan-2-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

(3s,5s)-5-[(3s,8s,9r,9as)-8-hydroxy-9-[(2s)-1-(5-hydroxy-3-methoxy-4-methylfuran-2-yl)-1-oxopropan-2-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one

C23H33NO7 (435.2257)

(5z)-5-{1-hydroxy-2-[8-hydroxy-3-(4-methyl-5-oxooxolan-2-yl)-octahydro-1h-pyrrolo[1,2-a]azepin-9-yl]propylidene}-4-methoxy-3-methylfuran-2-one

(5z)-5-{1-hydroxy-2-[8-hydroxy-3-(4-methyl-5-oxooxolan-2-yl)-octahydro-1h-pyrrolo[1,2-a]azepin-9-yl]propylidene}-4-methoxy-3-methylfuran-2-one

C23H33NO7 (435.2257)